5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.12▼ | 2.12▼ | 2.11▼ | 2.05▲ | 2.29▼ |
MA10 | 2.11▼ | 2.11▼ | 2.11▼ | 2.03▲ | 2.71▼ |
MA20 | 2.09▲ | 2.09▲ | 2.09▲ | 2.36▼ | 3.67▼ |
MA50 | 2.05▲ | 2.06▲ | 2.07▲ | 2.89▼ | 8.61▼ |
MA100 | 2.06▲ | 2.21▼ | 2.38▼ | 3.98▼ | N/A |
MA200 | 2.20▼ | 2.51▼ | 2.67▼ | 7.12▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | 0.001▲ | 0.007▲ | 0.013▲ | 0.145▲ |
RSI | 50.845▲ | 50.595▲ | 50.124▲ | 27.450▼ | 20.287▼ |
STOCH | 65.993 | 65.993 | 61.091 | 41.075 | 12.148▼ |
WILL %R | -32.353 | -32.353 | -32.353 | -56.000 | -82.570▼ |
CCI | -23.638 | -23.638 | 3.391 | -36.107 | -111.747▼ |
Wednesday, June 29, 2022 01:05 PM
SAN DIEGO and SUZHOU, China, June 29, 2022 (GLOBE NEWSWIRE) -- (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that ...
|
Monday, June 27, 2022 03:01 AM
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
|
Monday, June 27, 2022 03:01 AM
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
29/06/22 | 2.06 | 2.17 | 2.0311 | 2.095 | 479,793 |
28/06/22 | 2.265 | 2.265 | 2.055 | 2.07 | 21,593 |
27/06/22 | 2.08 | 2.21 | 1.98 | 2.10 | 121,391 |
24/06/22 | 2.05 | 2.23 | 1.98 | 2.00 | 81,961 |
23/06/22 | 1.99 | 2.025 | 1.88 | 2.00 | 48,351 |
22/06/22 | 1.96 | 2.15 | 1.896 | 2.00 | 53,850 |
21/06/22 | 1.96 | 2.22 | 1.96 | 2.05 | 50,666 |
17/06/22 | 2.00 | 2.19 | 1.89 | 2.00 | 40,811 |
16/06/22 | 2.05 | 2.388 | 1.99 | 1.99 | 33,411 |
15/06/22 | 2.28 | 2.65 | 1.60 | 2.00 | 1,361,012 |
|
|
||||
|
|
||||
|
|